White & Case (New York)

Dan Grossbaum

White & Case (New York)

Daniel Grossbaum is an associate in White & Case’s New York office and a member of the Firm’s Global Competition and Antitrust Group. Mr. Grossbaum’s practice focuses on complex antitrust matters, commercial matters, and counselling, and regularly represents global companies on novel antitrust and intellectual property issues. Mr. Grossbaum also maintains an active pro bono practice, with a particular focus on education-related matters. Mr. Grossbaum graduated from New York University School of law cum laude in 2016, where he served as managing editor of the New York University Environmental Law Journal.

Linked authors

White & Case (Brussels)
White & Case (Washington)
White & Case (Boston)
White & Case (Riyadh)
White & Case (New York)


185 Bulletin

Mark J. Gidley, Noah A. Brumfield, Jack E. Pace, Kristen O’Shaughnessy, Dan Grossbaum, Bryan D. Gant The US State of California becomes the first State to enact legislation rendering certain pharmaceutical patent litigation settlement agreements presumptively anticompetitive


This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On October 7, 2019, California became the first state to enact legislation— Assembly Bill 824 (“AB 824”)—rendering certain pharmaceutical patent litigation (...)

Send a message